An m1A/m6A/m5C-associated long non-coding RNA signature: Prognostic and immunotherapeutic insights into cervical cancer.
Chenxiang PanJiali LinXiaoxiao DaiLili JiaoJinsha LiuAidi LinPublished in: The journal of gene medicine (2023)
The risk model, associated with MRG-linked lncRNA, holds promise in forecasting clinical outcomes and gauging the efficacy of immunotherapies for CC patients.